Publications by authors named "Karyn Geiger"

Claim this Profile
S
Seeing the Trees From the Forest: Challenges in Subgroup Analysis-Based Guidelines in Oncology.
Ofer Rotem, Karyn Revital Geiger, Ekaterina Hanovich, Mor Moskovitz, Noga Kurman

Oncol Rev· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.
Osnat Bairey, Alisa Taliansky, Amir Glik, Alexandra Amiel, Shlomit Yust-Katz, Karyn Revital Geiger

Cancer· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious complications and long-term outcomes in patients with diffuse large B-Cell lymphoma and diabetes mellitus.
Oren Pasvolsky, Tamar Berger, Karyn Revital Geiger, Amit Akirov, Elias Bshara

Leuk Lymphoma· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Repeat biopsy in relapsed or refractory diffuse large B cell lymphoma: a nationwide survey and retrospective study.
Tamar Berger, Karyn Revital Geiger, Moshe Yeshurun, Anat Gafter-Gvili, Tzippy Shochat

Leuk Lymphoma· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of steroid treatment on the diagnostic yield of baseline f-fluorodeoxyglucose positron emission tomography in aggressive B cell lymphoma.
Karyn Revital Geiger, Oren Pasvolsky, Tamar Berger, Pia Raanani, Tzippy Shochat

EJNMMI Res· September 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hemophagocytic lymphohistiocytosis as a harbinger of aggressive lymphoma: a case series.
Oren Pasvolsky, Adi Zoref-Lorenz, Uri Abadi, Karyn Revital Geiger, Lucille Hayman

Int J Hematol· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diminished bile acids excretion is a risk factor for coronary artery disease: 20-year follow up and long-term outcome.
Gideon Charach, Ori Argov, Karyn Geiger, Lior Charach, Ori Rogowski

Therap Adv Gastroenterol· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis